NASDAQ: ELVN · Biotechnology
Over the past week, Enliven Therapeutics (ELVN) drew 12 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 50% bullish across the tracked sources. Wall Street is more constructive, with 12 of 12 analysts rating ELVN a buy.
There is little buzz around ELVN this week and broad agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 50% to X at 50%. No other tracker puts the two side by side.
12 analysts have weighed in: a Strong Buy consensus: 12 buy calls against 0 sell, with an average 12-month price target of $73.67.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits right on the neutral line, momentum is mixed and the 2 sources broadly agree, so the read is Hold rather than a clear buy or sell.
Analysts sit 50 points above the crowd average of 50%, the professionals are more constructive than retail. The split is inside the crowd: X reads 50% bullish while News sits at 50%, a 0-point spread that single-source trackers miss.
Over the 30-day window, Enliven Therapeutics (ELVN) buzz held subdued around 38.4 while the price drifted down 24.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.6M shares. Updated Oct 10, 2026. Over the last 7 trading days, ELVN lost 11.3%. Buzz activity in the recent week averaged 32.4 and was relatively stable, swinging between 23.4 and 40.8. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 5 of the 10 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for ELVN and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ELVN sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (12 / 0 / 0) |
| Crowd bullish (7d) | 50% |
| Avg price target | $73.67 |
| Most bullish source | X, 50% |
| Most bearish source | News, 50% |
| Sentiment spread | 0 pts |
| Mentions (7d) | 12 |
| Market cap | $2.98B |
| EPS · Beta | -$1.67 · 0.3 |
| Industry | Biotechnology |
Based on aggregated sentiment from X and News sources, Enliven Therapeutics (ELVN) currently carries an Adanos hold signal with 64/100 conviction. The current cross-source average reads 50% bullish across 2 active sources. Those sources contribute 12 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads split on Enliven Therapeutics (ELVN), averaging 50% bullish across 2 tracked sources over the last 7 days. The two ends of the range are X at 50% bullish and News at 50%, a 0-point spread. On the professional side, 12 of 12 analysts rate ELVN a buy.
Of the 12 analysts covering Enliven Therapeutics (ELVN), 12 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $73.67. That puts the street ahead of the crowd, which averages 50% bullish.
Enliven Therapeutics (ELVN)'s cross-source average is mixed at 50% bullish. All 2 tracked sources sit at 50% bullish. News reads 50% bullish and x coverage is the most negative at 50% bullish. The combined signal points to broad mixed pressure with 64/100 conviction.
The cross-source average is mixed for Enliven Therapeutics (ELVN) at 50% bullish. All 2 tracked sources sit at 50% bullish. The most bearish reading is x at 50% bullish. 3-day activity momentum is falling on News, while x activity is rising. The hold signal carries 64/100 conviction.
News is the dominant discussion channel with 8 mentions (67% of total volume). X contributes 4 mentions. The cross-source average is mixed at 50% bullish, while x is the only source with rising 3-day activity. All 2 tracked sources sit at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ELVN's hold signal at 64/100 conviction reflects a mixed cross-source average at 50% bullish. All 2 tracked sources sit at 50% bullish. It is a research shortcut, not financial advice.
The ELVN sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key